Boule Diagnostics AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	20.82	-349.7	39.27	28.97	36.02
Depreciation & Amortization	-	18.6	22.94	24.62	-	-
Other Adjustments	-0.21	0.14	795.67	21.36	14.99	15.31
Change in Receivables	23.48	33.48	-8.99	-19.27	-15.15	-33.7
Changes in Inventories	4.93	-4.17	-2.92	8.85	-9.78	-3.05
Changes in Accounts Payable	-16.01	-42.91	9.94	13.03	-15.19	33.38
Changes in Income Taxes Payable	-8.49	-3.79	-5.67	-9.98	-15.2	-4.67
Operating Cash Flow	22.13	0.83	46.58	51.38	-11.35	43.28
Operating Cash Flow Growth	126.27%	-98.22%	-9.34%	-	-	-42.47%
Capital Expenditures	-3.69	-3.49	-8.9	-6.87	-6.43	-3.15
Purchases of Intangible Assets	-4.18	-1.48	-77	-75.84	-68.53	-53.22
Investing Cash Flow	-7.86	-4.96	-85.9	-82.71	-74.96	-56.37
Long-Term Debt Issued	-21.17	14.6	38.41	-11.51	25.71	38.2
Long-Term Debt Repaid	-	-5.27	0	-	-	-
Net Long-Term Debt Issued (Repaid)	-21.17	9.33	38.41	-11.51	25.71	38.2
Issuance of Common Stock	-	-	-	-	149.51	-
Net Common Stock Issued (Repurchased)	-	-	-	-	149.51	-
Common Dividends Paid	-	-	-	-	-10.68	-10.68
Other Financing Activities	-4.12	-6.02	-14	-14	-23.99	-11.77
Financing Cash Flow	-17.69	3.31	24.41	-25.51	140.55	15.75
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.1	-13.54	0.71	0.36	4.49	2.53
Net Cash Flow	-3.43	-0.83	-14.91	-56.84	54.24	2.67
Free Cash Flow	18.44	-2.66	37.68	44.51	-17.79	40.14
Free Cash Flow Growth	430.52%	-	-15.35%	-	-	-43.20%
FCF Margin	4.00%	-0.54%	6.75%	7.79%	-3.25%	8.66%
Free Cash Flow Per Share	1.13	-0.07	0.97	1.15	-0.62	1.47
Levered Free Cash Flow	-48.17	-30.17	-242.79	43.12	-8.17	83.98
Unlevered Free Cash Flow	-63.24	-48.96	-272.11	62.23	-28.92	51.65